文献速递皮肤肿瘤

性别差异:男性黑色素瘤预后较女性更差

Sex matters: men with melanoma have a worse prognosis than women.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-07-16

结果显示男性诊断时肿瘤更厚、年龄更大、溃疡更多且多位于躯干或头颈,多变量校正后男性相对死亡风险仍显著升高(RER 1.37,95%CI 1.31-1.45)。

要点

  • 男性黑色素瘤患者诊断时肿瘤更厚(中位Breslow厚度1.00 mm vs 女性0.82 mm)。
  • 男性诊断时年龄更大,溃疡型及躯干/头颈部位黑色素瘤更常见。
  • 多变量校正后男性相对死亡风险仍显著高于女性(RER 1.37,95%CI 1.31-1.45)。

核心结论

  • 男性和女性黑色素瘤患者存在明显的临床病理差异,多变量校正这些差异后男性相对生存仍更差。

研究设计与样本

  • 采用多变量相对超额风险(RER)比较男女性相对生存。

主要发现

  • 2000年队列中男性占41.7%,2014年升至47.3%(P < 0.001);2000年死亡队列中男性占51.5%,2014年升至60.1%(P < 0.001)。
  • 男性诊断时中位Breslow厚度为1.00 mm(IQR 0.60-2.00),女性为0.82 mm(IQR 0.50-1.50),男性显著更厚。
  • 男性诊断时年龄显著更大,溃疡型黑色素瘤及躯干或头颈部位黑色素瘤更常见。
  • 女性生存随时间改善而男性生存下降(P < 0.001)。
  • 多变量分析中男性相对死亡风险RER为1.37(95%CI 1.31-1.45)。

临床怎么用

  • 临床医生应关注男性黑色素瘤患者预后更差的性别差异,对高风险男性加强预防和早期筛查。
  • 预防活动应整合并针对特定风险特征人群,以提高黑色素瘤的早期发现率并降低死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Europe, one of the highest melanoma incidences is found in the Netherlands. Like in several other European countries, females are more prone to develop melanoma as compared to males, although survival is worse for men. OBJECTIVE: To identify clinicopathological gender-related differences that may lead to gender-specific preventive measures. METHODS: Data from the Dutch Nationwide Network and Registry of Histopathology and Cytopathology (PALGA) were retrieved from patients with primary, cutaneous melanoma in the Netherlands between 2000 and 2014. Patients initially presenting as stage I, II and III without clinically detectable nodal disease were included. Follow-up data were retrieved from the Netherlands Cancer Registry. Gender-related differences were assessed, and to compare relative survival between males and females, multivariable relative excess risks (RER) were calculated. RESULTS: A total of 54.645 patients were included (43.7% men). In 2000, 41.7% of the cohort was male, as compared to 47.3% in 2014 (P < 0.001). Likewise, in 2000, 51.5% of the deceased cohort was male compared to 60.1% in 2014 (P < 0.001). Men had significantly thicker melanomas at the time of diagnosis [median Breslow thickness 1.00 mm (interquartile range (IQR): 0.60-2.00) vs. 0.82 mm (IQR: 0.50-1.50) for females] and were significantly older at the time of diagnosis, more often had ulcerated melanomas and melanomas localized on the trunk or head and neck. Over time, survival for females improved while that of men decreased (P < 0.001). RER for dying was 1.37 (95% CI: 1.31-1.45) for men in multivariable analysis. CONCLUSION: There are evident clinicopathological differences between male and female melanoma patients. After multivariable correction for all these differences, relative survival remains worse for men. Clinicians as well as persons at risk for melanoma should be aware of these differences, as awareness and prevention might lead to a lower incidence and mortality of melanoma. This indicates the need of prevention campaigns integrating and targeting specific risk profiles.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. El Sharouni MA, Witkamp AJ, Sigurdsson V, et al. Sex matters: men with melanoma have a worse prognosis than women. J Eur Acad Dermatol Venereol. 2019. PMID: 31246315. doi:10.1111/jdv.15760

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。